- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Kite, A Gilead Company
Total 45 results
-
Kite, A Gilead CompanyRecruitingRelapsed and/or Refractory B-cell LymphomaUnited States, Netherlands, United Kingdom, Germany
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Kite, A Gilead CompanyActive, not recruitingAcute Myeloid LeukemiaUnited States, France
-
Kite, A Gilead CompanyActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-Hodgkin LymphomaUnited States, France
-
Kite, A Gilead CompanyTerminatedMultiple Myeloma | Ovarian Cancer | Fallopian Tube Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Mantle Cell LymphomaUnited States, France, Spain, United Kingdom, Netherlands, Germany
-
Kite, A Gilead CompanyApproved for marketingRelapse/Refractory Mantle Cell LymphomaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Kite, A Gilead CompanyRecruitingHigh-risk Large B-cell Lymphoma (LBCL)United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
-
Kite, A Gilead CompanyAvailableAcute Lymphoblastic Leukemia | Mantle Cell LymphomaUnited States
-
Kite, A Gilead CompanyAvailableFollicular Lymphoma | Large B-cell LymphomaUnited States, Japan
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory Mantle Cell LymphomaUnited States, Netherlands, Germany, France
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Germany, Netherlands, Canada
-
Kite, A Gilead CompanyCompletedB-cell LymphomaUnited States, Australia, France
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell LeukemiaUnited States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Follicular LymphomaUnited States, Spain, United Kingdom, Italy, France, Japan, Germany
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
Kite, A Gilead CompanyActive, not recruitingRelapsed or Refractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)United States, Spain, United Kingdom, Canada, Netherlands, Germany, France, Sweden, Israel, Switzerland, Belgium, Australia, Austria, Italy
-
Kite, A Gilead CompanyCompletedRefractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic LymphomaUnited States, Italy
-
Kite, A Gilead CompanyApproved for marketingRelapsed/Refractory Diffuse Large B Cell Lymphoma | Relapsed/Refractory Primary Mediastinal B Cell Lymphoma | Relapsed/Refractory Transformed Follicular Lymphoma | Relapsed/Refractory High-Grade B-Cell LymphomaUnited States
-
Kite, A Gilead CompanyTerminated
-
Kite, A Gilead CompanyPfizerTerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyArcellx, Inc.Not yet recruiting
-
Kite, A Gilead CompanyArcellx, Inc.RecruitingMultiple MyelomaUnited States
-
Kite, A Gilead CompanyGenentech, Inc.CompletedRefractory Diffuse Large B Cell LymphomaUnited States
-
Kite, A Gilead CompanyHumanigen, Inc.TerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyArcellx, Inc.RecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
University of PennsylvaniaKite, A Gilead CompanyRecruiting
-
Vanderbilt-Ingram Cancer CenterKite, A Gilead CompanyActive, not recruitingDiffuse Large B-cell Lymphoma | Large B-cell LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterKite, A Gilead CompanyCompletedClear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
Fondazione Italiana Linfomi - ETSKite, A Gilead CompanyNot yet recruitingNon-hodgkin Lymphoma,B CellItaly
-
Dana-Farber Cancer InstituteKite, A Gilead CompanyActive, not recruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.; Kite, A Gilead CompanyRecruiting
-
M.D. Anderson Cancer CenterKite, A Gilead Company; Acerta Pharma, LLCRecruitingLymphoma | Mantle Cell LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyRecruitingAcute Lymphoblastic Leukemia | B-Cell Lymphoblastic LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyRecruitingLarge B-cell Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyActive, not recruitingDiffuse Large B Cell Lymphoma | Transformed LymphomaUnited States
-
Marcela V. Maus, M.D.,Ph.D.Kite, A Gilead CompanyActive, not recruitingNon Hodgkin Lymphoma | Neurotoxicity | Neurotoxicity Syndromes | Cytokine Release Syndrome | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
University of PennsylvaniaNational Institutes of Health (NIH); Tmunity Therapeutics, a wholly owned subsidiary...Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Lung Adenocarcinoma | Peritoneal Carcinoma | Mesotheliomas Pleural | Mesothelioma PeritoneumUnited States
-
Johns Hopkins Bloomberg School of Public HealthColumbia University; Sanofi Pasteur, a Sanofi Company; Institute of Epidemiology... and other collaboratorsCompletedInfluenza | Vaccine Response Impaired | Micronutrient Deficiency | Arsenic--Toxicology | Immunologic Disorders Complicating PregnancyBangladesh